BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 3091401)

  • 1. Purification and characterization of recombinant murine immune interferon.
    Nagata K; Kikuchi N; Ohara O; Teraoka H; Yoshida N; Kawade Y
    FEBS Lett; 1986 Sep; 205(2):200-4. PubMed ID: 3091401
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Purification and structural characterization of recombinant rat gamma-interferon from Escherichia coli.
    Lai CY; Dharm E; Fujii Y
    Anal Biochem; 1989 Feb; 176(2):326-9. PubMed ID: 2500869
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recombinant chicken IFN-gamma expressed in Escherichia coli: analysis of C-terminal truncation and effect on biologic activity.
    Michalski WP; Shiell BJ; O'Neil TE; Beddome G; Lowenthal JW
    J Interferon Cytokine Res; 1999 Apr; 19(4):383-92. PubMed ID: 10334390
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biological activity of hamster interferon-gamma is modulated by the carboxyl-terminal tail.
    Zhao W; Valencia AZ; Melby PC
    Cytokine; 2006 Jun; 34(5-6):243-51. PubMed ID: 16843003
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of polycationic C-terminal portion in the structure and activity of recombinant human interferon-gamma.
    Arakawa T; Hsu YR; Parker CG; Lai PH
    J Biol Chem; 1986 Jun; 261(18):8534-9. PubMed ID: 3087976
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Purification and characterization of recombinant mouse interferon-beta.
    Matsuda S; Utsumi J; Kawano G
    J Interferon Res; 1986 Oct; 6(5):519-26. PubMed ID: 3543158
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cloning, sequence, and expression of bovine interferon-gamma.
    Cerretti DP; McKereghan K; Larsen A; Cosman D; Gillis S; Baker PE
    J Immunol; 1986 Jun; 136(12):4561-4. PubMed ID: 3086437
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Production, purification and characterization of recombinant human interferon gamma.
    Zhang Z; Tong KT; Belew M; Pettersson T; Janson JC
    J Chromatogr; 1992 Jun; 604(1):143-55. PubMed ID: 1639923
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Optimization of conditions for expression of recombinant interferon-γ in E.coli.
    Kumar M; Singh M; Singh SB
    Mol Biol Rep; 2014 Oct; 41(10):6537-43. PubMed ID: 25001590
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Escherichia coli-derived human interferon-gamma with Cys-Tyr-Cys at the N-terminus is partially N alpha-acylated.
    Honda S; Asano T; Kajio T; Nishimura O
    Arch Biochem Biophys; 1989 Mar; 269(2):612-22. PubMed ID: 2493219
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression in Escherichia coli of cDNA encoding barley beta-amylase and properties of recombinant beta-amylase.
    Yoshigi N; Okada Y; Sahara H; Koshino S
    Biosci Biotechnol Biochem; 1994 Jun; 58(6):1080-6. PubMed ID: 7765034
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recombinant human interferons.
    Otto B
    Arzneimittelforschung; 1985; 35(11):1750-2. PubMed ID: 2418848
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oligomeric structure of recombinant human and murine immune interferons by means of sedimentation equilibrium.
    Nagata K; Izumi T; Kitagawa T; Yoshida N
    J Interferon Res; 1987 Jun; 7(3):313-20. PubMed ID: 3112251
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structure and activity of glycosylated human interferon-gamma.
    Arakawa T; Hsu YR; Chang D; Stebbing N; Altrock B
    J Interferon Res; 1986 Dec; 6(6):687-95. PubMed ID: 3106525
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential purification by immunoaffinity chromatography of two carboxy-terminal portion-deleted derivatives of recombinant human interferon-gamma from Escherichia coli.
    Honda S; Asano T; Kajio T; Nakagawa S; Ikeyama S; Ichimori Y; Sugino H; Nara K; Kakinuma A; Kung HF
    J Interferon Res; 1987 Apr; 7(2):145-54. PubMed ID: 3112244
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of C-terminal processing on the activity of human interferon-gamma.
    Arakawa T; Narachi MA; Hsu YR; Everett RR; Lai PH; Fish EN
    Drug Des Deliv; 1989 May; 4(3):217-25. PubMed ID: 2518759
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Purification of recombinant human immune interferon.
    Kung HF; Pan YC; Moschera J; Tsai K; Bekesi E; Chang M; Sugino H; Honda S
    Methods Enzymol; 1986; 119():204-10. PubMed ID: 3093802
    [No Abstract]   [Full Text] [Related]  

  • 18. Carboxy-terminal truncated rhuIFN-gamma with a substitution of Gln133 or Ser132 to leucine leads to higher biological activity than in the wild type.
    Slodowski O; Böhm J; Schöne B; Otto B
    Eur J Biochem; 1991 Dec; 202(3):1133-40. PubMed ID: 1662603
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Purification of interferon gamma-interferon gamma receptor complexes by preparative electrophoresis on native gels.
    Fountoulakis M; Takacs-di Lorenzo E; Juranville JF; Manneberg M
    Anal Biochem; 1993 Feb; 208(2):270-6. PubMed ID: 8452221
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structural characterization of human interferon gamma. Heterogeneity of the carboxyl terminus.
    Pan YC; Stern AS; Familletti PC; Khan FR; Chizzonite R
    Eur J Biochem; 1987 Jul; 166(1):145-9. PubMed ID: 3109913
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.